Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

An Oral Ketamine Drug for Depression — Minus the Trip?

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Europe’s AI Reality: Practice Outpaces Policy and Reviews

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Info on Risk for Prostate Cancer Spurs Decision-Making

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Rimegepant Effective in Treatment-Resistant Migraine

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Todays Updates

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

Todays Updates

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

Latest News

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

News All Time

Most Cardiology Is Geriatric Cardiology: Expert Tips

Geriatric cardiologists John Dodson and Ashok Krishnaswami discuss key tips and strategies for managing older adult cardiac patients.

Debunking Diet and Cancer Myths in the Clinic

Dr Shikha Jain separates fact from fiction on sugar, toxic supplements, and the clinical power of exercise in oncology.

Breast Implants: Is Routine 10-Year Exchange Needed?

The widely cited 10-year timeline for breast implant replacement may reflect tradition more than evidence, with experts instead emphasizing long-term surveillance.

Prostate Drug Shows Mixed Results for Lower Urinary Symptoms

Men had nearly three fewer daily symptoms with tamsulosin than on placebo.

Mental Health Bidirectionally Linked to Cognition in Pain

Mental health conditions are linked to a 78% higher risk for cognitive impairment (CI) in older adults with chronic pain, while CI is tied to higher MHC risk, research shows.

When Medical Mistrust, Wellness, and Politics Align

Decades of systemic failure have left patients feeling more heard outside the clinic than in it. Here’s what doctors can do.

Weight Loss While Taking Antipsychotics: Which Rx Works Best

Researchers analyzed data on 39 weight-loss drugs taken by patients on antipsychotics for schizophrenia. Which one offered the best results?

Treat-to-Target Strategy Is Feasible in Elderly-Onset RA

A treat-to-target approach appears feasible in patients with elderly-onset rheumatoid arthritis, with similar disease control and safety profiles as those with younger-onset disease, a study finds.

High Eye Pressure? Vitamin B3 May Shield Against Glaucoma

Supplementation with vitamin B3 is associated with a 66% lower risk of developing glaucoma in people with high eye pressure, a real-world study shows.

Nursing Faculty Shortage Is Limiting the RN Pipeline

There are too few nursing faculty to educate the next generation of nurses.

Most Child Flu Deaths Occur in Those Unvaccinated

Children and adolescents who die from influenza-related illness are less likely to have received the vaccine for the current season, per an analysis of pediatric deaths over eight seasons in the US.

Game Changers: How Lorlatinib Shifts the Landscape

Dr Mark Kris breaks down why lorlatinib is a true game changer in ALK+ NSCLC, offering unprecedented 5-year PFS data alongside essential strategies to manage its unique toxicities.

FDA Psychiatry Roundup: June 2026

A monthly overview of FDA actions for psychiatric treatments and therapies.

CADe Succeeds in Real-World Colonoscopy QI Study

AI-based computer-aided detection devices during colonoscopy was associated with higher adenoma detection rates than usual care, a pragmatic, quality improvement trial shows.

Adjunctive Trauma Therapy May Help Improve Psychosis Care

Trauma-focused therapy is associated with reduced PTSD symptom severity and increased remission in patients with co-occurring psychosis, a new randomized trial shows.

APOL1 Status May Refine Long-Term Kidney Donor Risk

High-risk APOL1 genotypes are associated with greater long-term kidney dysfunction among Black living donors, suggesting a potential role for genetic screening during donor evaluation.

Recommended News For You

Medical debt in collections persists after cancer diagnosis

Early, virtual palliative care feasible for advanced lung cancer

Year in Review: Chronic Lymphocytic Leukemia

Psychiatric Disorders Are Common in Dementia Patients.

Remote monitoring can improve recovery from cancer surgery

Researchers discover cellular 'doorway' exploited by cancer-causing virus

Abemaciclib Slows Progression of Advanced Liposarcoma

Recommended Articles For You

Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy 

Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia 

Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances 

Advanced Directions in Oncology and Quality Improvement 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

2.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

3.

Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results

4.

Oncology Drug Shortages Persist, but Continue to Evolve

5.

Are patients with advanced cancer receiving treatment aligned with their goals?

1.

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization

2.

Hematopoietic Aging Signatures and Future Hematologic Disease Risk

3.

Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025

4.

Clinical Frameworks in Oncology and Quality Improvement

5.

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

3.

Efficient Management of First line ALK-rearranged NSCLC - Part II

4.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot